- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Design
- Digital Marketing Rights
- DRM
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Review Of The 4th Amendment Of China’s Patent Law
On 17 October 2020, twelve years after the third amendment of China’s Patent Law, the fourth amendment (hereinafter, ‘the Amendment’) was approved by the Standing Committee of the National People’s Congress. The Amendment will come into effect on 1 June 2021. Many of these changes were a part of the proposed draft amendments released in … Continue reading Review Of The 4th Amendment Of China’s Patent Law
Read more »USA-China Trade War: An Overview
What is a Trade War? Trade war is one of the issues that may affect the associated alliances and eventually lead to influence the other sectors as well. As noted above trade war can result from protectionist penchant. Protectionism represents actions of the Government and policies made by it to restrict international trade, generally having … Continue reading USA-China Trade War: An Overview
Read more »No Monopoly over Hepatitis C- SIPO
A long battle over the monopoly control of Hepatitis C medicine was concluded by China’s State Intellectual Property Office (SIPO). SIPO has cancelled the Patent claims for oral drug hepatitis C drug ‘sofosbuvir’, which was earlier granted to US pharmaceutical corporation Gilead Sciences. This drug was an important medicine that was used for treatment of … Continue reading No Monopoly over Hepatitis C- SIPO
Read more »Smart IP: Blockchain Technology in China
What is blockchain? Blockchain is open ledger of information where people can record and track transactions which can be exchanged and confirmed on a peer-to-peer network. It allows multiple users to verify the transaction & control how record of information is amended and updated. Administrator keeps control of database and further provides access and permission … Continue reading Smart IP: Blockchain Technology in China
Read more »China’s Focus on Improving IPR Protection and Become Power House of IP
The history of Chinese intellectual property has only progressed intermittently. During Second World War, China had no system of Patent Protection. In 1980s, it became a member of the World Intellectual Property Organization (WIPO), and started developing intellectual property laws that governed and protected the rights of Chinese inventions. There seem to be an evolution … Continue reading China’s Focus on Improving IPR Protection and Become Power House of IP
Read more »